Publications

  1. Kaushik, A., Kest, H., Zauk, A., Debari, V., Lamacchia, M. The Impact of Routine MRSA surveillance & cohorting on MRSA related bloodstream infection (BSI) in the NICU. Am J Perinat (in press).
  2. Abou Jaoude, R., Zauk, A.,Morel, C., McClure, D., Lamacchia, M., Debari, V. Fluconazole prophylaxis is associated with a decreased rate of coagulase-negative Staphylococcal infections in a subset of extremely low birth weight neonates. Med Microbiol Immunol.  Vol. 203:4, 251-256, 2014
  3. Pineda, C., Kaushik, A., Kest, H., Wickes, B.,Zauk, A.  Maternal sepsis, Chorioamnionitis and Congenital Candida kefyr Infection in Premature Twins.  Pediatr Infect Dis  J.  Vol 31:3, 210-322, 2012
  4. Kalra, V., Debari, V., Zauk, A., Kataria, P., Myridakis, D., Kiblawi, F. Point of Care Testing for B-type Natriuretic Peptide in Premature Neonates with Patent Ductus Arteriosus.  Ann of Clini Lab Sci, Vol. 41: 2, 131 – 137, 2011.
  5. De, A., Sen, S., Flora, C., Ibrahim, J., Zauk, A..  Beckwith-Wiedemann Syndrome in a Patient with Klinefelter Syndrome.  The Internet Journal of Pediatrics and Neonatology 2009:  Vol 10 Number 2, 1-7.
  6. Horbar, J.D. and the Vermont Oxford Network (Zauk, A, Skroce L.) Collaborative quality improvement to promote evidence based surfactant for preterm infants:  A cluster randomized trial.  BMJ 329; 1004 – 1012. 2004.
  7. Lucey J. and the Vermont Oxford Network.  Fetal Infants:  The fate of 4172 infants with birth weights of 401 to 1500 grams. The Vermont Oxford Experience (1996 – 2000)  Pediatrics Vol 113:6, 1559 – 1566. 2004.
  8. Horbar, J.D. and the Vermont Oxford Network  (Zauk, A.)  Trends in Mortalityand Morbidity for Very Low Birth Weight Infants, 1991 – 1999.  Pediatrics Vol 110:1,143-151, 2002.
  9. Suresh, G.K.,Horbar, J.D., Kenny, M., Carpenter, J.H. and the Vermont Oxford Network (Zauk, A.). Major birth defects in very low birth weight infants in the Vermont Oxford Network.  J. Pediatr 139:3, 366-373, 2001.
  10. The Vermont Oxford Network Study Group (Zauk, A., DiLallo, D.)  Early postnatal Dexamethasone Therapy for the prevention of chronic lung disease.  Pediatrics Vol 108: 3, 741-748,2001.
  11. Bernstein, I.M., et al. and the Vermont Oxford Network (Zauk, A., DiLallo, D.) Mortality and Morbidity among very low birth weight neonates with intrauterine Growth restrictions. Am J Obstet Gynecol 182; 1:198 - 206, 2000.
  12. Finer, N.N., Horbar, J.D., Carpenter, H.C., and the Vermont Oxford Network (Zauk, A., DiLallo, D.) Cardiopulmonary resuscitation in the very low birth Weight infant.  The Vermont Oxford Network Experience.  Pediatrics 104; 3:428-434, 1999.
  13. Zauk, A. Instruments of success:  Profiling Ventilator Technology.  The Seton Perinatal Newsletter Vol 17, No. 2, 1-3, 1999.  Zauk, A., NO - Gas Therapy for The next millennium.  The Seton Perinatal Center Newsletter 15, 1, p. 1-3, 1999.
  14. Zauk, A., Antenatal Steroids Case Study.  The Seton Perinatal Center Newsletter, Vol.15, No.1, p.1,1996.
  15. Zauk, A., Current Concepts in Phototherapy.  The Seton Perinatal Center Newsletter, Vol. 15, No. 2, p. 1-4, 1996.
  16. Gardiner, J., Zauk, A., Donchey, S., McInerney, V.:  Prostaglandin-induced cortical hyperostosis.  Case report and review of the literature.  J Bone Joint Surg. 77A, 6:932-936,1995.
  17. Labagnara, J., Zauk, A., Rankin, L., Valda, V.:  Enteric duplications of the mouth. tolaryngol Head Neck Surg 108, 2:187-189, 1993.
  18. Zauk, A., Perlman, J.:  Transplacental salicylate poisoning.  Neonatal Intensive Care 6,2:26-28, 1993.
  19. Zauk, A.:  Delivery room management of the meconium stained newborn.  The Seton Perinatal Center Newsletter 12,3:2-3, 1993.
  20. Zauk, A.:  Surfactant...New drug for the 90’s. The Seton Perinatal Center Newsletter 10, 2:1-5, 1991.
  21. Gardiner, J., Zauk, A., Minnefor, A., et al:  Pyomyositis in an HIV positive premature infant.  Case report and review of the literature.  J Pediatr Orthop 10:791-793, 1990.
  22. Zauk, A.:  Yeasts isolated from vaginitis cases:  etiologic role and predisposing factors.Thesis for the acquisition of the diploma of Medicine Mycology, 1982.

Publications/Abstracts

  1. Abou Jaoude, R., Zauk, A., Kest, H., Lamacchia, M., Debari, V:  Fluconazole Prophylaxis Decreases the Rate of Coagulase-negative Staphylococcal Infections in a 2023, 2012.  Oral presentation at the 132nd Meeting of the Association of Clinical Scientists, Mobile, AL, May 2012.
  2. Attas, N., McClure, D., Skroce, L., Zauk, A:  Invasive Candidiasis in a Neonatal Intensive Care Unit:  Fluconazale prophylaxis implementation.  Poster Presentation at the 21st annual meeting of the Pediatric Pharmacy Advocacy Group, Houston, TX, April 2012
  3. Kaushik, A., Kest, H., Debari, V., Zauk, A., Lamacchia, M.:  Routine MRSA surveillance and cohorting:  Does it impact MRSA disease in the NICU?
    • Poster presentation at the 2011NJ Neoforum, Bedminster, NJ.
    • Platform presentation at New York Academy of Medicine Annual ResearchPresentation (NYAM), New York, March 30, 2011: Received the “New York Academy Recognition Award for Research in Pediatrics”, March 30, 2011
    • Abstract and poster presentation at the 2011 Pediatric Academic Societies’ & Asian Society for Pediatric Research Joint Meeting, April 30-May 3, 2011, Denver, Colorado
    • Abstract and poster presentation at the Infectious Diseases Society of America (IDSA) 49th Annual Meeting, October 20-23, 2011, Boston MA
  4. Dewera, A., Kaushik, A., Zauk, A., Kest, H.:  Super phones, super bugs? Do cell phones play a role in multi-drug resistant organism (MRDO) transmission? Oral presentation at the 2011 Research Day.   Research Institute of St. Joseph’s, May 2011.
    Second prize award
  5. Patel, J., Zauk, A., Pua, Z., DeBari, V:  Determining the Effectiveness of the TPN Calculator Software in NICU setting.  Poster presentation at the 2009 AAP National Conference and Exhibition, Washington, DC, October 2009.
  6. McClure, D., Skroce, L., Zauk, A.:  Reducing blood stream infections in the  NICU.  Poster presentation at the NJ Neoforum, Basking Ridge, NJ, June  2009.
  7. Valdivieso, Y.M., Kalra, V.K., Zauk, A., Patel, P., Kulikova, R.:  Transient Neonatal Myasthenia Gravis (MG):  A Case Report.  Poster presentation at the 20th Annual Research Colloquium, Seton Hall University, May 2009.
  8. De, A., Zauk, A., Ibrahim, J.:  Beckwith-Wiedemann Syndrome in a Patient  with Klinefelter Syndrome.  Poster presentation at the 20th Annual Research  Colloquium, Seton Hall University, May 2009.
  9. Kumaresan, K., Lesser, E., Zauk, A.:  A Standard Format for Perinatal  Counseling, Does It Work?  Poster presentation at the 20th Annual Research Colloquium, Seton Hall University, May 2009.
  10. Kalra, V.K., Kiblawi. F., Zauk, A., DeBari, V.A.:  Plasma Brain Natriuretic  Peptide as a Biochemical Marker for Patent Ductus Arteriosus in Pre-Term  Neonates.  Oral presentation at the 20th Annual Research Colloquium, Seton Hall University, May 2009.  First prize award in the category of clinical investigation.
  11. Kiblawi, F.M., Kalra, V.K., Zauk, A., Faber, K.:  Can B-type natriuretic  peptide (BNP) levels predict moderate and large Patent Ductus Arteriosus  (PDA) in preterm infants?   Poster presentation at the 2009/PAS/SPR Society  for Pediatric Research Meeting, Baltimore, MD, May 2009.   
  12. Kalra, V.K.,  Kiblawi, F.M., Zauk, A., Debari, V.A.:  Plasma Brain Natriuretic  Peptide as a biochemical Marker for Patent Ductus Arteriosus in Preterm Neonates.  Oral presentation at the 129th Meeting of the Association of Clinical Scientists, Tampa, FL, May 2009
  13. Rodriguez-Mejia, D.C., Kest, H., Zauk, A., Arcilla, T.:  Clinically Relevant Isolates (CRI) and MDRO in Preterm Neonates admitted to the Neonatal  Intensive Care Unit (NICU):  Deaths and Threats.  Presented at the 48th  Annual ICAAC/IDSA 46th Annual Meeting.  (Poster Presentation)  Washington, DC, October 2008. 
  14. Pham, K., Zauk, A., Kiblawi, F.:  Multiple Cycles of IV Ibuprofen Lysine for PDA  Closure in Neonates.  Presented at the 2008 Pediatric Pharmacy  Conference/17th  Annual PPAG Meeting. (Poster Presentation) Baltimore, MD, October 2008.
  15. Soll, R., and the Vermont Oxford Network (Zauk, A., Skroce, L).:  Early Surfactant  replacement in spontaneously breathing infants with RDS.  Presented at the Pediatric  Academic Societies Meeting Seattle, Washington, May 3 - 6, 2003.
  16. Krishnan, J., Lesser, E., Zauk, A., Bithoney W.:  Spontaneous Pneumothorax  and Renal Anomalies; A sonographic evaluation presented at the Greater New  York Conference on Perinatal Conference, White Plains, NY. October 12- 13, 2000.
  17. Hayajneh, W., Lesser, E., Zauk, A.:  Congenital Histocytosis presenting as a  blueberry muffin rash (Abstr.), presented at the Greater New York Conference on  Perinatal Research.  Hauppauge, New York,  Nov. 6-7, 1997.
  18. Zauk, A., Gill, S.:  GBS Osteomyelitis presenting as Erb’s Palsy, presented at the  6th Annual Research Colloquium, Seton Hall University, May 12, 1995.
  19. Zauk, A., Gill, S.: GBS Osteomyelitis presenting as Erb’s Palsy, presented at the 6th  New Jersey statewide Newborn Conference April 7, 1995 Piscataway, New York.
  20. Gardiner, J., Zauk, A.:  Prostaglandin-induced cortical Hyperostosis.  Case report and  review of the literature, (Abstr), presented at the Greater New York, Conference on  Perinatal Research.  Glen Cove, New York Oct. 28-30, 1992.
  21. Gardiner, J., Zauk, A.:  Prostaglandin-induced cortical hyperostosis in infants, a new  entity (Abstr) presented at the NY-NJ Orthopedic-Society meeting, Grand Cayman,  Cayman Islands April 7-12, 1992.
  22. Zauk, A., Congenital enteric duplication cyst of the mouth (Abstr), presented at  the Fourth Annual New Jersey Statewide Newborn Conference, Secaucus, New  Jersey March 27, 1992.
  23. Zauk, A., Perlman, J.:  Respiratory Distress in a Neonate:  A manifestation of  transplacental salicylate poisoning (Abstr), presented at the Neonatal and Infant Respiratory Symposium, Vail, Colorado March 16-19, 1992.
  24. Hurlet-Jensen, A., Zauk, A., Seaman, C.:  Effect of maternal corticosteroid treatment on the occurrence of Intraventricular hemorrhage and on the level of antithrombin III in premature infants. Pediatr Res 27, 4 (II): 265A, Abstr. 1990.
  25. Zauk, A.:  Intrauterine salicylate poisoning (Abstr.) presented at the Second New  Jersey Statewide Newborn Conference, Short Hills, New Jersey March 2, 1990.
  26. Hurlet-Jensen, A., Zauk, A.:  Role of antithrombin III in newborn hemostasis.   Thromb Haemost 62, I:288, Abstr 1989.
  27. Zauk, A., Rosen, T.:  Consequences of in-utero exposure to “crack” in the premature  infant.   Pediatr Res 25, 4 (II) 237A, Abstr 1989.
  28. Sanocka, U., Zauk, A., Menken, G., et al:  Does prenatal cocaine exposure increase the risk for brain lesions in L.B.W. infants?  Pediatr Res 25, 4 (II): 230 Abstr. 1989.
  29. Hurlet-Jensen, A., Zauk, A.:  Antithrombin III in the newborn with respiratory distress syndrome.  Blood 72, 5 (Suppl. I): 298a, Abstr. 1988.
  30. Hurlet-Jensen, A., Zauk, A., Antithrombin III in the neonate:  an immunological study. Pediatr Res 23, 4 (II): 464A, Abstr. 1988.
  31. Hurlet-Jensen, A., Zauk, A.:  Immunological studies of Antithrombin III in neonates. Blood 70,5 (Suppl.I):  405a Abstr. 1987.
  32. Sanocka, U., Zauk, A., Driscoll, J., James, L.S.:  Incidence and severity of intracranial hemorrhage in extremely small premature infants.  Pediatr Res 21, 4 (II):   477A Abstr. 1987.


Adel M. Zauk

Adjunct Associate Professor

 

  • :(973) 754-2555
  • DEPARTMENTDepartment of Pediatrics
    New York Medical College
  • COUNTRY USA